Skip to content
Hi-Doctor

How to Get CagriSema Online in Toulouse

If you're searching for CagriSema online in Toulouse, France, it's important to understand its current status. CagriSema is an experimental treatment and is not currently approved for weight-loss prescription in the EU.

24 April 2026
How to Get CagriSema Online in Toulouse

How to Get CagriSema Online in Toulouse

If you're searching for CagriSema online in Toulouse, France, it's important to understand its current status. CagriSema is an experimental treatment and is not currently approved for weight-loss prescription in the EU. This means Hi-Doctor does not offer it. However, your interest in advanced weight-loss solutions is valid. This article will explain what CagriSema is, why it isn't a normal option yet, and critically, what proven, EU-approved weight-loss treatments you CAN safely access today through an EU-licensed doctor.

What is Cagrisema, and why isn't it a normal option yet?

CagriSema is a novel investigational medication developed by Novo Nordisk, combining two active compounds: semaglutide (a GLP-1 receptor agonist) and cagrilintide (an amylin analogue). While semaglutide is already approved in various forms for weight management, cagrilintide is still undergoing clinical trials. The combination aims to offer enhanced weight loss and metabolic benefits. Currently, CagriSema is in Phase 3 clinical trials, meaning it's still being rigorously tested for safety and efficacy. It has not yet received approval from the European Medicines Agency (EMA) or the U.S. Food and Drug Administration (FDA) for commercial use. Consequently, it is not legally available for prescription in France or any other EU country. Seeking unapproved or counterfeit versions online poses significant health risks due to unknown purity, dosage, and potential contaminants.

Proven weight-loss medications available online today

While CagriSema is not an option, several highly effective, EU-approved weight-loss medications are available through an online consultation with an EU-licensed doctor.

  • Ozempic (semaglutide): An injectable GLP-1 receptor agonist, prescribed for type 2 diabetes but often used off-label for weight management when appropriate, under strict medical supervision.
  • Wegovy (semaglutide): A higher-dose formulation of semaglutide specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.
  • Mounjaro (tirzepatide): A GIP and GLP-1 receptor agonist, approved for type 2 diabetes and also demonstrating significant efficacy in weight loss, available for prescription when medically indicated.
  • Saxenda (liraglutide): An injectable GLP-1 receptor agonist approved for weight management, typically prescribed for daily use.

How to get a weight-loss prescription online in [your EU country]

Getting a prescription for an approved weight-loss medication through Hi-Doctor is a straightforward and secure process:

  1. Complete an online questionnaire: Spend 2–3 minutes providing essential medical information about your health and weight-loss goals.
  2. EU-licensed doctor reviews your case: An experienced Hi-Doctor physician, licensed within the EU, will carefully assess your questionnaire and medical history to determine if a weight-loss treatment is appropriate for you.
  3. Receive your REMPE prescription: If approved, you will receive a valid REMPE electronic prescription (a Spanish standard, valid EU-wide) within 24 hours. This is delivered as a downloadable PDF to your private account and by email.
  4. Pick up at any EU pharmacy: Present your digital or printed prescription at any pharmacy in France, or any other EU country, thanks to cross-border prescription directive 2011/24/EU. The online consultation fee is a flat 25 €, refunded automatically if treatment is deemed inappropriate.

Why choose Hi-Doctor over unregulated peptide sellers

When it comes to your health, safety and efficacy are paramount. Choosing Hi-Doctor ensures you receive legitimate, approved medications under professional medical supervision, unlike the significant risks associated with unregulated peptide sellers. Hi-Doctor connects you with EU-licensed doctors who conduct individual case reviews, ensuring your treatment is safe and appropriate. Our platform guarantees real medications from real pharmacies, with auditable, RGPD-compliant chat records. With over 50,000 patients served and a 4.8 Trustpilot rating, Hi-Doctor provides a trusted, traceable path to effective weight management, contrasting sharply with the unknown risks of 'research chemicals' or grey-market vendors lacking medical oversight.

Frequently asked questions

Is CagriSema legal to buy online in Spain?

No, CagriSema is not yet approved by the EMA, making it illegal to buy or sell for medical use in Spain or any other EU country. Any online source claiming to offer it is operating outside regulatory guidelines.

When will CagriSema be available by prescription?

CagriSema is currently in Phase 3 clinical trials. It will only be available by prescription after it successfully completes these trials and receives regulatory approval from bodies like the EMA, a process that can take several years.

What's the closest approved alternative to CagriSema?

The closest approved alternatives are GLP-1 receptor agonists and GIP/GLP-1 agonists like Wegovy (semaglutide) and Mounjaro (tirzepatide), which are proven for weight management and available by prescription through an EU-licensed doctor today.

How much does an online weight-loss consultation cost?

A consultation with an EU-licensed doctor through Hi-Doctor costs 25 €. If the doctor determines that treatment is not appropriate for you, this fee is automatically refunded.

Can I use a Hi-Doctor prescription at any pharmacy?

Yes, your REMPE electronic prescription from Hi-Doctor is valid at any pharmacy in any EU country, including France, under the cross-border prescription directive 2011/24/EU.

HI-DOCTOR NEWSLETTER

We'll tell you when we add new treatments.

At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.